How it Works
Galvani’s lead therapy aims to treat Rheumatoid Arthritis by stimulating the splenic nerve.
Galvani is currently enrolling Rheumatoid Arthritis patients in clinical studies within the US and UK. These studies may provide relief to individuals suffering from Adult-onset RA of at least six months duration.
